New ‘Doctor Who’ companion introduced

Classic Dungeons & Dragons back in print! - Available now @ Dungeon Masters Guild

58-year-old Scottish actress Lindsay Duncan will join David Tennant in the TARDIS, according to a report by the U.K.’s Daily Record that quotes producer Russell T. Davies.

Duncan will play Adelaide — “the Doctor’s most strong-minded companion yet” — in a still-untitled TV special that will follow Easter’s “Planet of the Dead,” starring Tennant and erstwhile Bionic Woman star Michelle Ryan.

“I’m thrilled to be involved in Doctor Who,” Duncan told the Record. “I’ve never done anything like this before and I’m really looking forward to working with David Tennant and the Doctor Who team.”

Duncan’s most recent credits include a role as the first female prime minister of Great Britain in the BBC’s Thatcher, 18 episodes of HBO’s Rome (pictured) and two appearances on the spy thriller Spooks, better known in the U.S. as MI-5. According to IMDb, she also provided the voice of the Trade Federation protocol droid TC-14 in Star Wars — Episode I: The Phantom Menace.

There’s no word yet on whether Adelaide will remain in the TARDIS for the two specials that will follow her debut and lead into the 2010 season, which will see Tennant depart as the Doctor regenerates into an 11th incarnation to be played by 26-year-old Matt Smith.

See also:

Sound decision: Revisiting the lost adventures of ‘Doctor Who’

Dark horse Matt Smith is youngest ‘Doctor Who’ star ever

BBC opens its archives to celebrate 45 years of ‘Doctor Who’

Subscribe for free updates!


View previous campaigns.

Powered by MailChimp

Nerdvana Media will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.